HBB and sickle cell disease: A previous report on the genetic correction of a beta hemoglobin gene to treat sickle cell disease in human hematopoietic stem/progenitor cells using ZFNs showed off-target cleavage in the highly homologous, but functionally dispensable, HBD gene [30].